SCHEMBL19919029

SCHEMBL19919029

COc1cc(C(=O)NCCO)ccc1Nc1ncc(C(F)(F)F)c(Oc2cccc3c2C(=O)N(C)C3)n1

nearest known ligand 0.90

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135610 0.94 PTK2 (1.00) PTK2
SCHEMBL12135613 0.93 PTK2 (1.00) PTK2
SCHEMBL19919025 0.92 PTK2 (0.88) PTK2
SCHEMBL16130908 0.92 PTK2 (0.90) PTK2
SCHEMBL12135601 0.91 PTK2 (1.00) PTK2
SCHEMBL19918899 0.91 PTK2 (0.89) PTK2
SCHEMBL12135585 0.90 PTK2 (1.00) PTK2
SCHEMBL23939882 0.89 PTK2 (0.81) PTK2
SCHEMBL12135603 0.89 PTK2 (1.00) PTK2
SCHEMBL12135590 0.89 PTK2 (1.00) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback